Enzolytics, Inc. (OTCMKTS:ENZC) Sees Large Increase in Short Interest

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 143,100 shares, a growth of 30.0% from the March 31st total of 110,100 shares. Based on an average trading volume of 9,305,200 shares, the short-interest ratio is currently 0.0 days.

Enzolytics Stock Performance

OTCMKTS:ENZC opened at $0.00 on Friday. Enzolytics has a one year low of $0.00 and a one year high of $0.01.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.